Roche, Sysmex Expand Long-Term Global Business Partnership
Extension complements pharmaceutical’s total lab solutions portfolio.
Roche has announced an expansion of its long-term alliance with Sysmex. As part of the renewed agreement, Roche is expected to continue offering Sysmex' hematology products. According to a company press release, the updated agreement also includes a new area of collaboration with an additional eco-social agreement to jointly explore more sustainable diagnostic solutions.
"We are delighted to expand our 25-year partnership with Sysmex in the area of hematology and in exploring more sustainable diagnostics solutions. Roche and Sysmex both have a long-standing history of delivering reliable and innovative solutions for patients and I am very happy to see this collaboration grow," said Matt Sause, CEO of Roche Diagnostics.
Reference: Roche expands long-term alliance with Sysmex. PR Newswire. August 3, 2023. Accessed August 7, 2023. https://www.prnewswire.com/news-releases/roche-expands-long-term-alliance-with-sysmex-301892152.html
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
